Open AccessPhase I Clinical Trial with a Novel Altered Peptide Ligand Derived from Human Heat-Shock Protein 60 for Treatment of Rheumatoid Arthritis: Safety, Pharmacokinetics and Preliminary Therapeutic Effects
Author(s) -
Dinorah Prada,
Jesús María Fernández Gómez,
N. Alcorta Lorenzo,
Oreste Corrales,
Ana Milena López López,
Evelio González,
Ania Cabrales,
Yusimy Reyes,
Yuliet Bermudez,
Yisel Ávila,
Lina Pérez,
Claudio Molinero,
O. Martínez,
Leonardo Oramas,
Yaysel Miñoso,
Yassel Ramos,
Hilda Garay,
Edwin G. Pérez,
M Oliveri López,
Osvaldo Reyes,
Yolanda Cruz,
Alfredo Hernández,
Cabal Carlos,
Vladimir Besada,
Luís Javier Durán González,
Gabrìel Padrón,
María del Carmen Domínguez Horta
Publication year - 2018
Publication title -
journal of clinical trials
Language(s) - English
Resource type - Journals
ISSN - 2167-0870
DOI - 10.4172/2167-0870.1000339
Subject(s) - rheumatoid arthritis , medicine , pharmacokinetics , clinical trial , heat shock protein , pharmacology , shock (circulatory) , safety profile , peptide , arthritis , bioinformatics , adverse effect , chemistry , biology , biochemistry , gene